Arete Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
VCM
VPM
Arete Wealth Advisors's IDXX Position: Q1 2026 in Review
Arete Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 469 shares — an estimated $317K sold.
Arete Wealth Advisors first reported a position in IDXX in Q3 2018 and held it in 19 quarters. The position peaked at $724M in Q4 2022. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Arete Wealth Advisors reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
- Arete Wealth Advisors sold 469 Idexx Laboratories shares in Q1 2026, an estimated $317K.
- Arete Wealth Advisors first reported a position in Idexx Laboratories in Q3 2018 and held it in 19 quarters.
- Arete Wealth Advisors's Idexx Laboratories position peaked at $724M in Q4 2022.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Arete Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.